Secondary surgical-site infection after coronary artery bypass grafting: A multi-institutional prospective cohort study
- PMID: 29221750
- PMCID: PMC5860945
- DOI: 10.1016/j.jtcvs.2017.10.078
Secondary surgical-site infection after coronary artery bypass grafting: A multi-institutional prospective cohort study
Abstract
Objective: To analyze patient risk factors and processes of care associated with secondary surgical-site infection (SSI) after coronary artery bypass grafting (CABG).
Methods: Data were collected prospectively between February and October 2010 for consenting adult patients undergoing CABG with saphenous vein graft (SVG) conduits. Patients who developed a deep or superficial SSI of the leg or groin within 65 days of CABG were compared with those who did not develop a secondary SSI.
Results: Among 2174 patients identified, 65 (3.0%) developed a secondary SSI. Median time to diagnosis was 16 days (interquartile range 11-29) with the majority (86%) diagnosed after discharge. Gram-positive bacteria were most common. Readmission was more common in patients with a secondary SSI (34% vs 17%, P < .01). After adjustment, an open SVG harvest approach was associated with an increased risk of secondary SSI (adjusted hazard ratio [HR], 2.12; 95% confidence interval [CI], 1.28-3.48). Increased body mass index (adjusted HR, 1.08, 95% CI, 1.04-1.12) and packed red blood cell transfusions (adjusted HR, 1.13; 95% CI, 1.05-1.22) were associated with a greater risk of secondary SSI. Antibiotic type, antibiotic duration, and postoperative hyperglycemia were not associated with risk of secondary SSI.
Conclusions: Secondary SSI after CABG continues to be an important source of morbidity. This serious complication often occurs after discharge and is associated with open SVG harvesting, larger body mass, and blood transfusions. Patients with a secondary SSI have longer lengths of stay and are readmitted more frequently.
Keywords: body mass index; coronary artery bypass grafting; postoperative length of stay; postoperative readmission; red blood cell transfusion; saphenous vein graft; surgical site infection.
Copyright © 2017 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Comment in
-
Surgical site infections after coronary artery bypass grafting-Does "never" really mean "never"?J Thorac Cardiovasc Surg. 2018 Apr;155(4):1563-1564. doi: 10.1016/j.jtcvs.2017.12.110. Epub 2018 Jan 6. J Thorac Cardiovasc Surg. 2018. PMID: 29370911 No abstract available.
-
Unachievable zeros.J Thorac Dis. 2018 Sep;10(Suppl 26):S3218-S3219. doi: 10.21037/jtd.2018.08.79. J Thorac Dis. 2018. PMID: 30370117 Free PMC article. No abstract available.
-
Validating innovations to improve recovery after heart surgery.Ann Transl Med. 2018 Nov;6(Suppl 1):S13. doi: 10.21037/atm.2018.09.23. Ann Transl Med. 2018. PMID: 30613588 Free PMC article. No abstract available.
-
Endoscopic saphenous vein harvesting and surgical site infections after coronary artery bypass surgery.Ann Transl Med. 2018 Nov;6(Suppl 1):S37. doi: 10.21037/atm.2018.09.51. Ann Transl Med. 2018. PMID: 30613612 Free PMC article. No abstract available.
-
Editorial on the article entitled "Secondary surgical-site infection after coronary artery bypass grafting: A multi-institutional prospective cohort study".J Thorac Dis. 2018 Nov;10(Suppl 33):S3938-S3941. doi: 10.21037/jtd.2018.09.70. J Thorac Dis. 2018. PMID: 30631521 Free PMC article. No abstract available.
-
Precision and targeted therapy in cardiac surgery.J Thorac Dis. 2018 Nov;10(Suppl 33):S3986-S3988. doi: 10.21037/jtd.2018.09.90. J Thorac Dis. 2018. PMID: 30631535 Free PMC article. No abstract available.
References
-
- Paletta C, Huang D, Fiore A, Swartz M, Rilloraza F, Gardiner J. Major Leg Wound Complications After Saphenous Vein Harvest for Coronary Revascularization. The Annals of Thoracic Surgery. 2000 Jul;:492–497. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
